Mutations in ABCA3 lead to surfactant deficiency and pulmonary diseases like fatal respiratory distress in newborns or chronic interstitial lung disease in children (chILD) and adults.13, 14 To date, no causal therapies exist to treat patients suffering from lung diseases due to ABCA3 mutations. Here, ABCA3 is linked to lung disorder.